Polyclonal Rabbit anti‑Human ANXA1 / Annexin A1 Antibody (Biotin, aa2‑26) LS‑C183753
Polyclonal Rabbit anti‑Human ANXA1 / Annexin A1 Antibody (Biotin, aa2‑26) LS‑C183753
Antibody:
ANXA1 / Annexin A1 Rabbit anti-Human Polyclonal (aa2-26) (Biotin) Antibody
Format:
Biotin, Unmodified
Overview
Antibody:
ANXA1 / Annexin A1 Rabbit anti-Human Polyclonal (aa2-26) (Biotin) Antibody
Format:
Biotin, Unmodified
Specifications
Description
Annexin A1 antibody LS-C183753 is a biotin-conjugated rabbit polyclonal antibody to human Annexin A1 (ANXA1) (aa2-26). Validated for ELISA.
Target
Human ANXA1 / Annexin A1
Synonyms
ANXA1 | Annexin A1 | Annexin I | Annexin-1 | ANX1 | Calpactin II | Chromobindin-9 | Lipocortin I | Annexin I (lipocortin I) | Calpactin-2 | LPC1
Reactivity
Human
(tested or 100% immunogen sequence identity)
Immunogen
Synthetic peptide corresponding to aa2-26 of human Ac2-26.
Specificity
Human Ac2-26.
Usage
The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested.
Storage
May be stored at 4°C for short-term only. Aliquot to avoid freeze-thaw cycles. Store at -20°C. Aliquots are stable for up to 1 year.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human, Monkey, Mouse, Rat, Bat, Bovine, Dog, Guinea pig, Hamster, Horse, Pig, Rabbit
Applications:
IHC, IHC - Paraffin, Western blot, Peptide Enzyme-Linked Immunosorbent Assay
Species:
Human, Mouse, Rat
Applications:
IHC, Western blot, ELISA
Species:
Human
Applications:
IHC, IHC - Paraffin, Immunofluorescence, Western blot
Species:
Human, Mouse
Applications:
IHC, IHC - Paraffin, Western blot
Species:
Human, Rat
Applications:
Western blot, ELISA
Species:
Mouse
Applications:
IHC, Western blot, ELISA
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 11/3/2024